Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

307

HTML

2574

Figures (1-2)

186

Tables (1-1)

182

Sum=3249

Jul 1, 2004 (publication date) through Nov 11, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jul 1, 2004; 10(13): 1971-1974
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1971

Table 1 Tumor volume of three groups (mean ± SD)

F = 27.95, P < 0.01 vs control group. No significant difference in volume was shown between sulindac group and celecoxib group.

Citation: Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 2004; 10(13): 1971-1974
URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1971.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i13.1971